🟢 Moleculin Biotech is trading 7.92% up in pre-market — no confirmed catalyst identified

Moleculin Biotech is trading 7.92% up at $0.73 in pre-market with no confirmed company-specific catalyst identified for September 4, 2026.

• Recent updates concern the MIRACLE trial’s planned September enrollment milestone and August financial results, rather than an overnight announcement.
• The broader market is modestly higher ahead of the U.S. jobs report, but no clear company, sector, or macro explanation has been established.